Gilead Sciences reported for 9 months of 2023

Gilead Sciences' GAAP net income for 9 months of 2023 was $4.196 billion, up 43.1% from $2.933 billion in the prior year. Revenues increased 0.5% to $20 billion from $19.892 billion a year earlier.